AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Mochida Pharmaceutical Co.,Ltd.
  3. Financials
  4. Revenue growth (%)

Mochida Pharmaceutical Co.,Ltd.【JP:4534】

Market cap
¥141.9B
P/E ratio
16.5x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRevenue growth (%) YoY (%)
Mar 31, 20252.2-713.89%
Mar 31, 2024-0.4-94.27%
Mar 31, 2023-6.3-189.97%
Mar 31, 20227+496.58%
Mar 31, 20211.2-116.36%
Mar 31, 2020-7.1-364.81%
Mar 31, 20192.7-72.08%
Mar 31, 20189.7+75.82%
Mar 31, 20175.5-4.35%
Mar 31, 20165.8-180.65%
Mar 31, 2015-7.1-234.27%
Mar 31, 20145.3+52.15%
Mar 31, 20133.5

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)